Role of drug "Tagaradi kwath" in the management of Anidra (Insomnia)

A Clinical study to evaluate the Therapeutic effect of drug "Tagaradi kwath" in the management of Anidra (Insomnia)

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036371

Enrollment

Registered

2021-09-09

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patient of Anidra suffering upto 3 months of duration. 2)Nidranasha(Insomnia) according to Athens Insomnia Scale. 3)Patient without any complication of other disease will include in this study.

Exclusion criteria

Exclusion criteria: 1)Anidra due to other conditions such as madatyaya,abhighata and othervsystemic diseases. 2)Patients on hypnotic medicine or other drugs known to cause drowsiness. 3)Patients with acute illness like myocardial infraction, congestive cardiac failure,COPD,meningitis,acute pain condition and similar other disease. 4)Patients with major psychiatric illness like epilepsy,schizophrenia,major depressive psychosis etc. 5)Patients having chronic disease like liver cirrhosis,asthma,malignancies,diabetes,hypertension and chronic renal failure

Design outcomes

Primary

Measure	Time frame
1)Relief in Angmarda 2)Relief in Sirogaurava 3)Relief in jrumbha 4)Relief in jadyata 5)Relief in bhrama 6)Relief in tandraTimepoint: 45th day	—

Secondary

Measure	Time frame
nillTimepoint: nill	—

Countries

India

Contacts

Public ContactDr Umesh Patil

Shubhdeep Ayurved Medical College And Hospital P.G Institute

doctoraksingh@yahoo.com9300681233

Outcome results